134 related articles for article (PubMed ID: 34442136)
1. Costs of Stroke and Incidence of First Diagnosis of Atrial Fibrillation at Time of Stroke. Neurology Ward Hospital Poznań, Poland 2018.
Zaprutko T; Florczak-Wyspiańska J; Kopciuch D; Paczkowska A; Ratajczak P; Dorszewska J; Nowakowska E; Kus K
Healthcare (Basel); 2021 Aug; 9(8):. PubMed ID: 34442136
[TBL] [Abstract][Full Text] [Related]
2. Costs of inpatient care of depression in 2014 in Polish (Poznan) and German (Kiel) hospital.
Zaprutko T; Göder R; Kus K; Pałys W; Nowakowska E
Int J Psychiatry Clin Pract; 2019 Nov; 23(4):258-264. PubMed ID: 31107117
[No Abstract] [Full Text] [Related]
3. The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016.
Zaprutko T; Göder R; Kus K; Pałys W; Rybakowski F; Nowakowska E
PLoS One; 2018; 13(6):e0198890. PubMed ID: 29902259
[TBL] [Abstract][Full Text] [Related]
4. The cost savings of newer oral anticoagulants in atrial fibrillation-related stroke prevention
.
Masbah N; Macleod MJ
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):220-230. PubMed ID: 28025962
[TBL] [Abstract][Full Text] [Related]
5. Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry.
Stępińska J; Kremis E; Konopka A; Wożakowska-Kapłon B; Ruszkowski P; Kukla P; Kayani G
Kardiol Pol; 2016; 74(4):362-71. PubMed ID: 26365937
[TBL] [Abstract][Full Text] [Related]
6. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
Cotté FE; Chaize G; Kachaner I; Gaudin AF; Vainchtock A; Durand-Zaleski I
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623
[TBL] [Abstract][Full Text] [Related]
7. Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation - a nationwide cohort study.
Jakobsen M; Kolodziejczyk C; Klausen Fredslund E; Poulsen PB; Dybro L; Paaske Johnsen S
BMC Health Serv Res; 2017 Jun; 17(1):398. PubMed ID: 28606079
[TBL] [Abstract][Full Text] [Related]
8. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Ma CS; Zint K; Elsaesser A; Bartels DB; Lip GY;
J Am Coll Cardiol; 2017 Feb; 69(7):777-785. PubMed ID: 28209218
[TBL] [Abstract][Full Text] [Related]
9. New oral anticoagulants for the prevention of thromboembolic complications in atrial fibrillation: a single centre experience.
Gorczyca-Michta I; Wożakowska-Kapłon B
Kardiol Pol; 2015; 73(2):85-93. PubMed ID: 25179482
[TBL] [Abstract][Full Text] [Related]
10. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
[TBL] [Abstract][Full Text] [Related]
11. The cost of inpatient care of schizophrenia in the Polish and Ukrainian academic centers--Poznan and Lviv.
Zaprutko T; Nowakowska E; Kus K; Bilobryvka R; Rakhman L; Pogłodziński A
Acad Psychiatry; 2015 Apr; 39(2):165-73. PubMed ID: 25216718
[TBL] [Abstract][Full Text] [Related]
12. The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001.
Ghatnekar O; Glader EL
Value Health; 2008; 11(5):862-8. PubMed ID: 18489491
[TBL] [Abstract][Full Text] [Related]
13. Comparing the economic burden of ischemic stroke patients with and without atrial fibrillation: a retrospective study in Beijing, China.
Wen L; Wu J; Feng L; Yang L; Qian F
Curr Med Res Opin; 2017 Oct; 33(10):1789-1794. PubMed ID: 28657348
[TBL] [Abstract][Full Text] [Related]
14. Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.
Le Heuzey JY; Bassand JP; Berneau JB; Cozzolino P; D'Angiolella L; Doucet B; Mantovani LG; Martelet M; Mouallem J; Muller JJ; Pieper K;
Arch Cardiovasc Dis; 2018 Dec; 111(12):749-757. PubMed ID: 29861295
[TBL] [Abstract][Full Text] [Related]
15. Societal Costs of First-Incident Ischemic Stroke in Patients with Atrial Fibrillation-A Danish Nationwide Registry Study.
Jakobsen M; Kolodziejczyk C; Fredslund EK; Poulsen PB; Dybro L; Johnsen SP
Value Health; 2016 Jun; 19(4):413-8. PubMed ID: 27325333
[TBL] [Abstract][Full Text] [Related]
16. Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands.
Jacobs MS; van Leent MWJ; Tieleman RG; Jansman FGA; Cao Q; Postma MJ; van Hulst M
J Med Econ; 2017 Dec; 20(12):1231-1236. PubMed ID: 28766370
[TBL] [Abstract][Full Text] [Related]
17. Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
Liu J; Wang Y; Guo W; Cheng Y; Zhang S; Wu B; Liu M
Int J Cardiol; 2021 Jan; 322():258-264. PubMed ID: 32814110
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
[TBL] [Abstract][Full Text] [Related]
19. Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay.
Song X; Sander SD; Johnson BH; Varker H; Amin AN
Am J Health Syst Pharm; 2012 Feb; 69(4):329-38. PubMed ID: 22302258
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016.
Maura G; Billionnet C; Drouin J; Weill A; Neumann A; Pariente A
BMJ Open; 2019 Apr; 9(4):e026645. PubMed ID: 31005934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
